Nanomaterials, particularly newer biopolymeric systems like chitosan, accelerated wound healing in fish studies by promoting tissue regeneration and dampening inflammatory markers. However, 75% of research used zebrafish rather than farmed species, leaving real-world aquaculture applications largely unexplored.
Researchers conducting a systematic review of 12 in vivo studies (published 2017-2026) identified a clear evolution in how nanomaterials are being tested for fish wound healing. Early work focused on metallic nanoparticles, specifically silver and zinc oxide formulations. The field has since shifted toward biopolymeric nano-delivery systems, with chitosan emerging as the dominant approach in recent studies. This pivot reflects a broader move toward safer, more sustainable treatments for farmed fish, where standard antibiotics and chemical baths have proven ineffective or unsafe.
The quantitative data showed consistent patterns: nanoparticle treatments accelerated wound closure across studies, with several formulations achieving over 90% wound healing within two weeks. The review authors stress these findings are "strictly descriptive due to high methodological heterogeneity," meaning the studies used different protocols, measures, and fish species, preventing formal meta-analysis. This is an important caveat. The underlying mechanisms, however, revealed more uniform results. Under microscopy, nanomaterial treatments accelerated re-epithelialization (the regrowth of surface tissue), improved collagen organization (the structural protein essential for scar formation), and reduced inflammatory infiltration.
At the molecular level, nanomaterials downregulated pro-inflammatory cytokines including IL-1β and TNF-α, while upregulating anti-inflammatory markers like IL-10 and TGF-β. Antioxidant enzyme activity also increased, with elevated superoxide dismutase (SOD) and catalase (CAT) reducing oxidative stress. Transcriptomics data indicated activation of fibroblast growth factor 7 (FGF7), a key driver of tissue regeneration, and the Jak-STAT signaling pathway, which coordinates immune response and cell survival. These molecular shifts align with wound healing processes in mammals, suggesting the mechanisms are evolutionarily conserved.
A critical limitation emerged: zebrafish (Danio rerio) comprised 75% of all study models. While zebrafish are valuable for basic research and genetic tractability, they are not farmed for food and have dramatically different skin physiology compared to commercially important species. The review identifies a major gap: Nile tilapia (Oreochromis niloticus), the world's most farmed fish by volume, has almost no nanomaterial wound-healing research. Furthermore, hybrid systems combining nano-hyaluronic acid and nano-chitosan have never been tested in farmed fish, despite their complementary biological properties and potential advantages.
This research is foundational science, not a consumer product story. The work is relevant primarily to aquaculture producers, fish health researchers, and pharmaceutical companies developing treatments for farmed fish. For human applications, the results are too preliminary and the model organism mismatch too severe to extrapolate.
However, the underlying mechanisms identified here may eventually inform wound-healing strategies in other domains. The observation that nanomaterials suppress pro-inflammatory cytokines while supporting tissue regeneration mirrors desired outcomes in human wound care. But significant translation work remains: moving from controlled lab conditions to farmed-fish environments, optimizing dosing and delivery systems for scale, and confirming safety and efficacy in the target species.
The shift from metallic to biopolymeric nanomaterials is noteworthy from a safety perspective. Biopolymers like chitosan are naturally derived, biodegradable, and pose fewer bioaccumulation risks than metals, making them more attractive for food-producing animals.
If you work in aquaculture, this review signals that nanomaterial wound treatments are advancing but remain experimental for your primary species. Advocating for industry-relevant research (on tilapia, salmon, catfish) rather than model organisms is warranted.
| Parameter | Value |
|---|---|
| Study type | Systematic review (PRISMA 2020) |
| Studies included | 12 in vivo studies (2017-2026) |
| Primary model organism | Zebrafish (75% of studies); other teleosts in minority |
| Nanoparticle types tested | Metallic (silver, zinc oxide); biopolymeric (chitosan-based) |
| Primary outcome measured | Wound closure rate, re-epithelialization, collagen organization |
| Molecular markers assessed | IL-1β, TNF-α, IL-10, TGF-β, SOD, CAT, matrix metalloproteinases, FGF7, Jak-STAT pathway |
| Key finding | Nanomaterials accelerated healing via anti-inflammatory and regenerative mechanisms; research heavily skewed toward non-farmed models |
| Journal | BMC Veterinary Research |
| PubMed ID | 42859172 |
Systematic review: "Morpho-molecular assessment of nanomaterials in teleost fish wound healing: a systematic review." BMC Veterinary Research. PubMed: 42859172
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.